Stock Report

All about this stock under one free report Last Updated: 05-Nov-2026

Stock Rating

See the stock’s health at a glance, before it's too late.

Wealth Insight New Issue

This month’s issue could change how you invest, read now.

Recently Viewed

Torrent Pharma Key Ratios

Stock Card factsheet watchlist-stock-modal share-fund-plan-icon

NSE: TORNTPHARM | BSE: 500420

₹4,738.50

up-down-arrow ₹88.50 (1.90%)

As on 04-Nov-2026IST

Market cap

info icon

₹1,79,914 Cr

Revenue (TTM)

info icon

₹17,400 Cr

P/E Ratio

info icon

84.7

P/B Ratio

info icon

9.8

Div. Yield

info icon

0.8 %

Key Ratios and Highlights

Growth Score (%) Quarterly Annual (TTM)
Particulars QoQ YoY 1-Year 3-Years 5-Years
Revenue 1.18 50.79 42.06 19.36 16.23
EBIT -1.31 20.25 21.02 19.06 15.70
Net Profit -7.04 -9.90 1.67 17.95 11.71
EPS -16.05 -19.60 -3.50 15.42 10.27
Book Value -- -- 10.51 10.61 7.52
Key Ratios (%) Average Annual (TTM)
Particulars3-Years5-YearsTTMMar-26Mar-25
EBIT-Margin info 27.8223.0322.1723.2825.26
Net Margin info 18.4513.7712.1015.2016.54
Return on equity info 24.6422.4616.4726.7626.46
Return on Capital info 22.8521.11--19.2727.32
Return on Assets info 12.359.436.987.3713.23
Debt to Equity (x) info ----0.631.760.40

Profitability

View Detailed Peer Comparison

ROCE

--

--

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Torrent Pharma
--
19.27
27.32
24.28
20.32
Peer Median
--
21.28
21.76
21.89
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROE

16.47

Higher than Peers by 1.64

Profit after tax / Average Net worth * 100

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Torrent Pharma
16.47
26.76
26.46
25.38
20.50
Peer Median
14.83
18.29
17.93
16.42
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROA

6.98

Lower than Peers by 2.86

Profit after tax / Average Total assets * 100

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Torrent Pharma
6.98
7.37
13.23
11.43
9.20
Peer Median
9.85
9.88
12.81
12.32
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Margin

22.17

Higher than Peers by 4.67

Operating profit (EBIT) / Net Sales * 100

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Torrent Pharma
22.17
23.28
25.26
23.82
22.01
Peer Median
17.50
18.36
18.93
21.05
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Margin

12.10

Lower than Peers by 1.31

Net profit / Total Income (Net sales plus other income) * 100

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Torrent Pharma
12.10
15.20
16.54
15.35
12.86
Peer Median
13.41
13.31
14.94
15.51
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Profit Margin

--

--

(Net profit + Depreciation) / Gross Sales * 100

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Torrent Pharma
--
16.55
16.06
14.75
11.96
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Growth

View Detailed Peer Comparison

Revenue Growth

42.06

Higher than Peers by 29.65

Year on year growth in net sales

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Torrent Pharma
42.06
21.39
7.35
11.51
13.07
Peer Median
12.41
13.53
10.90
13.44
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Growth

21.02

Lower than Peers by 1.83

Year on year growth in operating profit (EBIT)

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Torrent Pharma
21.02
11.85
13.86
20.68
19.69
Peer Median
22.85
20.72
15.01
23.50
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Profit Growth

1.67

Lower than Peers by 20.92

Year on year growth in profit after tax

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Torrent Pharma
1.67
11.87
15.39
33.02
60.22
Peer Median
22.58
19.61
14.80
30.12
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EPS Growth

-3.50

Lower than Peers by 24.83

Year on year growth in earnings per share

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Torrent Pharma
-3.50
13.19
15.39
33.02
60.23
Peer Median
21.33
18.87
14.27
29.02
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Book Value Growth

--

--

Year on year growth in book value per share

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Torrent Pharma
--
10.51
10.71
10.62
4.12
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Solvency

View Detailed Peer Comparison

Debt to Equity

0.63

Higher than Peers by 0.63

Total debt / Net worth

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Torrent Pharma
0.63
1.76
0.40
0.57
0.85
Peer Median
0.00
0.05
0.06
0.03
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Short term debt to equity ratio

--

--

(Short term borrowings / Net worth)

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Torrent Pharma
--
0.35
0.16
0.24
0.28
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Current Ratio

1.32

Lower than Peers by 0.71

Current Assets / Current Liabilities and Provisions

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Torrent Pharma
1.32
1.13
1.19
1.03
0.98
Peer Median
2.03
1.90
1.90
2.23
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Quick Ratio

0.92

Lower than Peers by 0.58

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Torrent Pharma
0.92
0.75
0.66
0.62
0.57
Peer Median
1.50
1.45
1.46
1.59
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Interest Coverage

4.17

Lower than Peers by 17.53

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Torrent Pharma
4.17
8.46
11.59
7.65
6.54
Peer Median
21.71
19.02
24.96
45.29
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Operating Efficiency

View Detailed Peer Comparison

Debtors to sales

19.53

Lower than Peers by 1.55

Debtors outstanding / Net Sales * 100

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Torrent Pharma
19.53
21.68
16.21
17.19
20.21
Peer Median
21.08
19.75
21.77
20.10
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Asset Turnover

0.58

Lower than Peers by 0.14

Sales / Average Total Assets

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Torrent Pharma
0.58
0.68
1.17
1.15
1.21
Peer Median
0.72
0.76
0.76
0.81
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Receivable days

--

--

Average Debtors / Sales * 365

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Torrent Pharma
--
45.41
40.18
41.38
39.99
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Inventory Days

--

--

Average Inventory / Sales * 365

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Torrent Pharma
--
52.67
52.20
49.26
52.47
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Payable days

--

--

Average Creditors / Cost of goods sold * 365

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Torrent Pharma
--
244.06
279.17
279.66
243.50
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Conversion Cycle

--

--

Receivable Days + Inventory Days - Payable Days

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Torrent Pharma
--
-145.98
-186.79
-189.03
-151.04
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Valuation

View Detailed Peer Comparison

Price / Earnings

84.71

Higher than Peers by 51.92

Current share price divided by earning per share in the last twelve months

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Torrent Pharma
84.71
66.03
57.28
53.15
41.79
Peer Median
32.79
34.92
26.81
39.85
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Price / Book Value

9.79

Higher than Peers by 5.39

Current share price divided by book value per share in the latest financial year

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Torrent Pharma
9.79
17.03
14.42
12.84
8.40
Peer Median
4.40
5.00
4.65
6.11
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Dividend Yield

0.80

Higher than Peers by 0.32

Dividend per share in the past twelve months divided by current share price

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Torrent Pharma
0.80
0.90
0.99
1.08
1.43
Peer Median
0.49
0.49
0.61
0.37
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EV/EBITDA

33.71

--

Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Torrent Pharma
33.71
35.05
29.89
26.61
19.66
Peer Median
--
25.69
27.02
34.57
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Market Cap

1,79,914

Higher than Peers by 1,62,382

Current Share price multiplied by latest total number of shares outstanding

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Torrent Pharma
1,79,914
1,42,852
1,09,478
88,038
52,033
Peer Median
17,532
16,891
20,914
25,297
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
loading...
loading...
loading...

Mutual Fund Insight turns 24! 🎉 Get 2 FREE anniversary guides: The Right SIP + The Big Funds